These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9839269)

  • 61. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency.
    Yumru AE; Bozkurt M; Inci Coşkun E; Baykan G
    J Int Med Res; 2009; 37(1):198-204. PubMed ID: 19215691
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overactive bladder.
    Margraf C
    Am J Nurs; 2002 Oct; 102(10):14; author reply 14. PubMed ID: 12449925
    [No Abstract]   [Full Text] [Related]  

  • 64. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
    Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW; Dailey ME; Rockhill B; Tipping D; Naughton MJ; Shumaker SA
    Psychosom Med; 2005; 67(1):98-104. PubMed ID: 15673630
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaginal hormone therapy for urogenital and menopausal symptoms.
    Ballagh SA
    Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Complication of a 2-mg estradiol vaginal ring: fibrotic vaginal adhesion.
    Pratts ME; Shen W
    Menopause; 2014 Nov; 21(11):1254-6. PubMed ID: 24937026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The menopause and HRT. Urogenital effects of hormone therapy.
    Robinson D; Cardozo L
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):91-104. PubMed ID: 12763514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urogenital atrophy. A new approach to vaginitis diagnosis.
    Carcio H
    Adv Nurse Pract; 2002 Oct; 10(10):40-8, 51. PubMed ID: 12424883
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause.
    Repse-Fokter A; Takac I; Fokter SK
    Gynecol Endocrinol; 2008 Jul; 24(7):399-404. PubMed ID: 18645712
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urogenital ageing: an old problem newly recognized.
    Bachmann G
    Maturitas; 1995 Dec; 22 Suppl():S1-S5. PubMed ID: 8775770
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy.
    Holmgren PA; Lindskog M; von Schoultz B
    Maturitas; 1989 Mar; 11(1):55-63. PubMed ID: 2498619
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alternatives to the use of estrogen in postmenopausal women.
    Pinkerton JV; Santen R
    Endocr Rev; 1999 Jun; 20(3):308-20. PubMed ID: 10368773
    [No Abstract]   [Full Text] [Related]  

  • 78. Web-based survey on the effect of digital storytelling on empowering women to seek help for urogenital atrophy.
    Cumming GP; Currie HD; Moncur R; Lee AJ
    Menopause Int; 2010 Jun; 16(2):51-5. PubMed ID: 20729493
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Local oestrogen replacement for local symptoms in older community dwelling women.
    Fonda D
    Gerontology; 1994; 40 Suppl 3():9-13. PubMed ID: 7851802
    [No Abstract]   [Full Text] [Related]  

  • 80. Geriatric aspects on estrogen effects and sexuality.
    Sourander LB
    Gerontology; 1994; 40 Suppl 3():14-7. PubMed ID: 7851799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.